Zion Labs Y2 Yohimbine Double 10mg 150 Caps

Description

Zion Labs Y2 Yohimbine Double 10mg 150 Caps

Zion Labs Y2 Yohimbine Double 10mg 150 Caps is a specialist capsule product featuring a declared double-source yohimbine formula.

Each container provides 150 capsules. Available product listings identify a total declared specification of 10 mg and describe the formula as a combination of yohimbine hydrochloride and a yohimbe-derived extract. Because the currently available listings do not provide a reliable quantitative breakdown for both components, the physical ingredient panel should be checked before the product is published or dispatched.

What is yohimbine?

Yohimbine is a biologically active indole alkaloid associated with the African yohimbe tree. Pharmacologically, it acts primarily as an antagonist of presynaptic alpha-2 adrenergic receptors and can influence sympathetic nervous-system activity. It should not be presented as a vitamin, mineral or ordinary nutritional ingredient.

Commercial listings frequently associate yohimbine products with stimulation, appetite control, fat reduction, energy or sexual function. These statements should not be presented as guaranteed, medically approved or clinically established effects of this particular commercial product.

Product specifications

• Brand: Zion Labs
• Product name: Y2 Yohimbine Double
• Declared specification: 10 mg
• Package size: 150 capsules
• Product form: capsules
• Reported active components: yohimbine HCl and yohimbe-derived extract
• Formula type: double-source yohimbine formula

The available listings do not clearly establish whether the declared 10 mg applies to one capsule, one serving or the combined amount of both forms under every label version. The serving size, precise quantitative composition, capsule shell, excipients and warnings must therefore be confirmed against the original bottle.

Product presentation and verification

A complete catalogue listing should allow customers to verify:

• the Zion Labs branding,
• the Y2 Yohimbine Double product name,
• the declared 10 mg specification,
• the 150-capsule package size,
• the exact quantity of each johimbine source,
• the complete ingredient panel,
• the batch and expiry information,
• the manufacturer or responsible operator,
• the condition of the original safety seal.

The physical label should remain the primary source for the final product specification. A container should not be distributed when the seal is damaged, the label appears altered or the product differs from the online description.

Safety information

Yohimbine can affect blood pressure, heart rate and the central nervous system. Reported safety concerns include anxiety, agitation, tremor, sleep disturbances, irregular heartbeat, blood-pressure problems, seizures and cardiovascular complications. The risk may be greater when combined with caffeine, pre-workout products, decongestants or other stimulants.

The term “double” should not be interpreted as evidence of improved safety or predictable activity. Plant extracts may contain variable amounts of active alkaloids, while the effects of yohimbine HCl depend on the actual quantity and purity of the ingredient.

This description is provided solely for product identification and catalogue-reference purposes. It does not provide dosage instructions, weight-loss guidance, medical recommendations or guarantees of results.